SCHEMBL6891601

SCHEMBL6891601

C=C1CCCC(C2(c3ccc(OC)cc3)N=C(C)C(=S)N2)C1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.35
SLC6A4 P31645 2/20 0.33
CYP3A4 P08684 1/20 0.33
CTSE P14091 1/20 0.33
CYP2C19 P33261 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HRH2 P25021 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932692 0.85 BACE1 (0.42) BACE1SLC6A4CYP3A4CTSECYP2C19
SCHEMBL945139 0.85 BACE1 (0.42) BACE1SLC6A4CYP3A4CTSECYP2C19
SCHEMBL945955 0.85 BACE1 (0.42) BACE1SLC6A4CYP3A4CTSECYP2C19
SCHEMBL945249 0.60 CHRNA1 (0.37) BACE1SLC6A4SLC6A2SLC6A3ALDH1A1
SCHEMBL4093476 0.58 MAOB (0.50) SLC6A4CYP3A4SLC6A3ALDH1A1ALOX15
SCHEMBL931861 0.58 BACE1 (0.53) BACE1SLC6A4CYP3A4CTSECYP2C19
SCHEMBL932399 0.58 BACE1 (0.53) BACE1SLC6A4CYP3A4CTSECYP2C19
SCHEMBL931327 0.58 BACE1 (0.53) BACE1SLC6A4CYP3A4CTSECYP2C19
SCHEMBL6893051 0.58 KDM2B (0.42) CYP2C19ALDH1A1LMNAHPGD
SCHEMBL8845648 0.57 SLC6A4 (0.45) BACE1SLC6A4CYP3A4CYP2C19SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed